Seager Matthew J, Patel Uday, Anderson Christopher J, Gonsalves Michael
1 Department of Radiology, St. George's Hospital , London , UK.
2 Department of Urology, St. George's Hospital , London , UK.
Br J Radiol. 2018 May;91(1085):20170666. doi: 10.1259/bjr.20170666. Epub 2018 Feb 22.
To study the influence of tumour diameter and anatomy on the success and complication rates of small renal mass (SRM, ≤4 cm) core biopsy.
Retrospective analysis of SRMs that underwent ultrasound or CT-guided biopsy. Diagnostic and complication rates were compared according to tumour size (subcategorised as axial diameter ≤2 cm, >2 to- ≤3 cm, >3-≤4 cm) and anatomical disposition (exophytic/endophytic, centrality, polar location and anterior/posterior).
94 patients (54 male; age range 21.8-84.3 years) with 95 SRMs underwent biopsy. The first biopsy was diagnostic in 81/95 (85.3%). Seven patients underwent repeat biopsy (6/7 diagnostic), to give an overall diagnostic rate of 91.5%. The primary diagnostic rates in the ≤2, >2-≤3 , >3-≤4 cm groups were 21/25 (84%); 38/44 (86.4%) and 22/26 (84.6%) respectively and were similar (p = 1.00). Anterior and upper pole SRMs were more likely to fail initial biopsy (odds ratio 13.8, p < 0.01; and odds ratio 4.35, p = 0.04) respectively, but other anatomical factors were not relevant. Complications occurred in 14% (all conservatively managed perinephric haematomas; Clavien-Dindo Grade 1) and size or location were not relevant.
Image-guided biopsy of SRMs has a high diagnostic rate irrespective of tumour size. Anterior and upper pole location had lower diagnostic rates. Biopsy should be considered for all patients with SRMs, if the result will impact on management and we list specific scenarios where an SRM biopsy may be helpful. Advances in knowledge: SRM size does not affect the likelihood of a diagnostic biopsy.
研究肿瘤直径及解剖结构对小肾肿块(SRM,直径≤4 cm)穿刺活检成功率及并发症发生率的影响。
对接受超声或CT引导下活检的小肾肿块进行回顾性分析。根据肿瘤大小(分为轴向直径≤2 cm、>2至≤3 cm、>3至≤4 cm)及解剖位置(外生性/内生性、中心性、极位及前/后位)比较诊断率及并发症发生率。
94例患者(54例男性;年龄范围21.8 - 84.3岁)的95个小肾肿块接受了活检。首次活检诊断阳性率为81/95(85.3%)。7例患者接受了重复活检(6/7诊断阳性),总体诊断率为91.5%。直径≤2 cm、>2至≤3 cm、>3至≤4 cm组的初次诊断率分别为21/25(84%)、38/44(86.4%)和22/26(84.6%),差异无统计学意义(p = 1.00)。前位及上极小肾肿块初次活检失败的可能性更高(优势比分别为13.8,p < 0.01;优势比4.35,p = 0.04),但其他解剖因素无关。并发症发生率为14%(均为肾周血肿保守治疗;Clavien-Dindo 1级),与肿瘤大小或位置无关。
无论肿瘤大小,影像引导下的小肾肿块活检诊断率均较高。前位及上极位置诊断率较低。若活检结果会影响治疗方案,所有小肾肿块患者均应考虑活检,我们列出了小肾肿块活检可能有用的具体情况。知识进展:小肾肿块大小不影响诊断性活检的可能性。